Related references
Note: Only part of the references are listed.A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus
Elisabet Svenungsson et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Association of STAT4 and BLK, but Not BANK1 or IRF5, With Primary Antiphospholipid Syndrome
Hong Yin et al.
ARTHRITIS AND RHEUMATISM (2009)
The balance between pro- and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients
A. M. Gori et al.
ATHEROSCLEROSIS (2009)
Premature vascular damage in systemic lupus erythematosus
Mariana J. Kaplan
AUTOIMMUNITY (2009)
The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus
Abraham L. Brass et al.
CELL (2009)
The innate immune system in SLE: type I interferons and dendritic cells
L. Roennblom et al.
LUPUS (2008)
Gene expression profiling for the identification of G-protein coupled receptors in human platelets
Stefan Amisten et al.
THROMBOSIS RESEARCH (2008)
Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus
Pui Y. Lee et al.
ARTHRITIS AND RHEUMATISM (2007)
Inteirferon-α promotes abnormal vasculogenesis in lupus:: a potential pathway for premature atherosclerosis
Michael F. Denny et al.
BLOOD (2007)
IFITM1 plays an essential role in the antiproliferative action of interferon-γ
G. Yang et al.
ONCOGENE (2007)
Genetically determined mannan-binding lectin deficiency is of minor importance in determining susceptibility to severe infections and vascular organ damage in systemic lupus erythematosus
A. Jonsen et al.
LUPUS (2007)
Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events
Aileen M. Healy et al.
CIRCULATION (2006)
The role of PACT in the RNA silencing pathway
Y Lee et al.
EMBO JOURNAL (2006)
Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation
KN Ekdahl et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Interferon-α in systemic lupus erythematosus
MK Crow et al.
CURRENT OPINION IN RHEUMATOLOGY (2004)
The association of antibodies to cardiolipin, β2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus
S Koskenmies et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2004)
Transcript profiling of human platelets using microaray and serial analysis of gene expression
DV Gnatenko et al.
BLOOD (2003)
Microarray analysis of gene expression in lupus
MK Crow et al.
ARTHRITIS RESEARCH & THERAPY (2003)
Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-γ, and IFN-α
F Atzeni et al.
CELLULAR IMMUNOLOGY (2002)
Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis
JE Joseph et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin - Studies in baboons, human coronary intervention, and human acute myocardial infarction
AD Michelson et al.
CIRCULATION (2001)
Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus
M Nagahama et al.
AUTOIMMUNITY (2001)
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
AA Bengtsson et al.
LUPUS (2000)
Share Paper
